Cover Image
Market Research Report

Asia Pacific Autoimmune Disease Therapeutics Market (2019-2025)

Published by KBV Research Product code 906236
Published Content info 108 Pages
Delivery time: 1-2 business days
Price
Back to Top
Asia Pacific Autoimmune Disease Therapeutics Market (2019-2025)
Published: July 31, 2019 Content info: 108 Pages
Description

The Asia Pacific Autoimmune Disease Therapeutics Market would witness market growth of 5.72% CAGR during the forecast period (2019-2025).

Autoimmune diseases can be understood as disorders in which the immune system erroneously attacks the patient's body. In the usual scenario, however, the immune system protects against germs such as bacteria and viruses by sending out an army of fighter cells to attack them when it senses these foreign invaders.

Asia-Pacific offers profitable expansion opportunities for main players working on the therapeutic market for autoimmune disease due to the large population base, increased buying power, increased autoimmune disease incidence, and increased demand for advanced autoimmune disease therapeutics. Growth in the number of aging populations and increased early detection of the disease with increased healthcare spending are anticipated to boost growth in this region's market for autoimmune disease therapeutics.

Based on Indication, the market is segmented into Rheumatic Disease, Diabetes, Multiple Sclerosis, Inflammatory Bowel Disease, and Other Indications. Based on Drug Class, the market is segmented into Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs (Nonsteroidal anti-inflammatory drugs), Interferons and Other Drugs. Based on the Distribution Channel, the market is segmented into Hospital Pharmacy, Online and Retail Pharmacies & Drug Stores. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include ABBOTT Laboratories, Bio-Rad Laboratories, Inc., Johnson and Johnson, GlaxoSmithKline PLC (GSK), Pfizer, Inc., Merck & Co., Inc., Bayer AG, AbbVie, Inc., Amgen, Inc. and Novartis.

Scope of the Study

Market Segmentation:

By Indication

  • Rheumatic Disease
  • Diabetes
  • Multiple Sclerosis
  • Inflammatory Bowel Disease
  • Other Indications

By Drug Class

  • Anti-Inflammatory
  • Anti-Hyperglycemics
  • NSAIDs
  • Interferons
  • Other Drugs

By Distribution Channel

  • Hospital Pharmacy
  • Online
  • Retail Pharmacies and Drug Stores

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific

Companies Profiled:

  • ABBOTT Laboratories
  • Bio-Rad Laboratories, Inc.
  • Johnson and Johnson
  • GlaxoSmithKline PLC (GSK)
  • Pfizer, Inc.
  • Merck & Co., Inc.
  • Bayer AG
  • AbbVie, Inc.
  • Amgen, Inc.
  • Novartis AG

Unique Offerings from KBV Research:

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Table of Contents

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Asia Pacific Autoimmune Disease Therapeutics Market, by Indication
    • 1.4.2 Asia Pacific Autoimmune Disease Therapeutics Market, by Drug Class
    • 1.4.3 Asia Pacific Autoimmune Disease Therapeutics Market, by Distribution Channel
    • 1.4.4 Asia Pacific Autoimmune Disease Therapeutics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
    • 2.1.2 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Asia Pacific Autoimmune Disease Therapeutics Market by Indication

  • 3.1 Asia Pacific Rheumatic Disease Market by Country
  • 3.2 Asia Pacific Diabetes Market by Country
  • 3.3 Asia Pacific Multiple Sclerosis Market by Country
  • 3.4 Asia Pacific Inflammatory Bowel Disease Market by Country
  • 3.5 Asia Pacific Other Indications Market by Country

Chapter 4. Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class

  • 4.1 Asia Pacific Anti-Inflammatory Market by Country
  • 4.2 Asia Pacific Anti-Hyperglycemics Market by Country
  • 4.3 Asia Pacific NSAIDs Market by Country
  • 4.4 Asia Pacific Interferons Market by Country
  • 4.5 Asia Pacific Other Drugs Market by Country

Chapter 5. Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel

  • 5.1 Asia Pacific Hospital Pharmacy Market by Country
  • 5.2 Asia Pacific Online Market by Country
  • 5.3 Asia Pacific Retail Pharmacies and Drug Stores Market by Country

Chapter 6. Asia Pacific Autoimmune Disease Therapeutics Market by Country

  • 6.1 China Autoimmune Disease Therapeutics Market
    • 6.1.1 China Autoimmune Disease Therapeutics Market by Indication
    • 6.1.2 China Autoimmune Disease Therapeutics Market by Drug Class
    • 6.1.3 China Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.2 Japan Autoimmune Disease Therapeutics Market
    • 6.2.1 Japan Autoimmune Disease Therapeutics Market by Indication
    • 6.2.2 Japan Autoimmune Disease Therapeutics Market by Drug Class
    • 6.2.3 Japan Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.3 India Autoimmune Disease Therapeutics Market
    • 6.3.1 India Autoimmune Disease Therapeutics Market by Indication
    • 6.3.2 India Autoimmune Disease Therapeutics Market by Drug Class
    • 6.3.3 India Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.4 South Korea Autoimmune Disease Therapeutics Market
    • 6.4.1 South Korea Autoimmune Disease Therapeutics Market by Indication
    • 6.4.2 South Korea Autoimmune Disease Therapeutics Market by Drug Class
    • 6.4.3 South Korea Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.5 Singapore Autoimmune Disease Therapeutics Market
    • 6.5.1 Singapore Autoimmune Disease Therapeutics Market by Indication
    • 6.5.2 Singapore Autoimmune Disease Therapeutics Market by Drug Class
    • 6.5.3 Singapore Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.6 Malaysia Autoimmune Disease Therapeutics Market
    • 6.6.1 Malaysia Autoimmune Disease Therapeutics Market by Indication
    • 6.6.2 Malaysia Autoimmune Disease Therapeutics Market by Drug Class
    • 6.6.3 Malaysia Autoimmune Disease Therapeutics Market by Distribution Channel
  • 6.7 Rest of Asia Pacific Autoimmune Disease Therapeutics Market
    • 6.7.1 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Indication
    • 6.7.2 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Drug Class
    • 6.7.3 Rest of Asia Pacific Autoimmune Disease Therapeutics Market by Distribution Channel

Chapter 7. Company Profiles

  • 7.1 ABBOTT Laboratories
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expense
  • 7.2 Bio-Rad Laboratories, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Johnson and Johnson
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental &Regional Analysis
    • 7.3.4 Research & Development Expenses
    • 7.3.1 Recent strategies and developments:
      • 7.3.1.1 Collaborations, partnerships and agreements:
  • 7.4 GlaxoSmithKline PLC (GSK)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Acquisition and mergers:
      • 7.4.5.2 Collaborations, partnerships and agreements:
      • 7.4.5.3 Product launches:
  • 7.5 Pfizer, Inc.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Collaborations, partnerships and agreements:
      • 7.5.5.2 Approval:
  • 7.6 Merck & Co., Inc.
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expenses
    • 7.6.5 Recent strategies and developments:
      • 7.6.5.1 Collaborations, partnerships and agreements:
      • 7.6.5.2 Acquisition and mergers:
  • 7.7 Bayer AG (Bayer Schering Pharma AG)
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Segmental and Regional Analysis
    • 7.7.4 Research & Development Expense
    • 7.7.5 Recent strategies and developments:
      • 7.7.5.1 Collaborations, partnerships and agreements:
  • 7.8 AbbVie, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Regional Analysis
    • 7.8.4 Research & Development Expense
    • 7.8.5 Recent strategies and developments:
      • 7.8.5.1 Collaborations, partnerships and agreements:
  • 7.9 Amgen, Inc.
    • 7.9.1 Company overview
    • 7.9.2 Financial Analysis
    • 7.9.3 Regional Analysis
    • 7.9.4 Research & Development Expense
    • 7.9.5 Recent strategies and developments:
      • 7.9.5.1 Product launches:
      • 7.9.5.2 Collaborations, partnerships and agreements:
  • 7.1 Novartis AG
    • 7.10.1 Company Overview
    • 7.10.2 Financial Analysis
    • 7.10.3 Segmental and Regional Analysis
    • 7.10.4 Research & Development Expense
    • 7.10.5 Recent strategies and developments:
      • 7.10.5.1 Acquisition and mergers:
      • 7.10.5.2 Collaborations, partnerships and agreements:

LIST OF TABLES

  • TABLE 1 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 2 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 3 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 4 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 5 ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 6 ASIA PACIFIC RHEUMATIC DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 7 ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 8 ASIA PACIFIC DIABETES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 9 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 10 ASIA PACIFIC MULTIPLE SCLEROSIS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 11 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 12 ASIA PACIFIC INFLAMMATORY BOWEL DISEASE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 13 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 14 ASIA PACIFIC OTHER INDICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 15 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 16 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 17 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 18 ASIA PACIFIC ANTI-INFLAMMATORY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 19 ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 20 ASIA PACIFIC ANTI-HYPERGLYCEMICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 21 ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 22 ASIA PACIFIC NSAIDS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 23 ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 24 ASIA PACIFIC INTERFERONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 25 ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 26 ASIA PACIFIC OTHER DRUGS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 27 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 28 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 29 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 30 ASIA PACIFIC HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 31 ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 32 ASIA PACIFIC ONLINE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 33 ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 34 ASIA PACIFIC RETAIL PHARMACIES AND DRUG STORES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 35 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
  • TABLE 36 ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
  • TABLE 37 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 38 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 39 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 40 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 41 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 42 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 43 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 44 CHINA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 45 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 46 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 47 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 48 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 49 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 50 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 51 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 52 JAPAN AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 53 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 54 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 55 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 56 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 57 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 58 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 59 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 60 INDIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 61 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 62 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 63 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 64 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 65 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 66 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 67 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 68 SOUTH KOREA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 69 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 70 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 71 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 72 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 73 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 74 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 75 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 76 SINGAPORE AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 77 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 78 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 79 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 80 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 81 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 82 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 83 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 84 MALAYSIA AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 85 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2015 - 2018, USD MILLION
  • TABLE 86 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET, 2019 - 2025, USD MILLION
  • TABLE 87 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2015 - 2018, USD MILLION
  • TABLE 88 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY INDICATION, 2019 - 2025, USD MILLION
  • TABLE 89 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2015 - 2018, USD MILLION
  • TABLE 90 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DRUG CLASS, 2019 - 2025, USD MILLION
  • TABLE 91 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
  • TABLE 92 REST OF ASIA PACIFIC AUTOIMMUNE DISEASE THERAPEUTICS MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
  • TABLE 93 KEY INFORMATION - ABBOTT LABORATORIES
  • TABLE 94 KEY INFORMATION - BIO-RAD LABORATORIES, INC.
  • TABLE 95 KEY INFORMATION -JOHNSON AND JOHNSON
  • TABLE 96 KEY INFORMATION - GLAXOSMITHKLINE PLC (GSK)
  • TABLE 97 KEY INFORMATION - PFIZER, INC.
  • TABLE 98 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 99 KEY INFORMATION - BAYER AG
  • TABLE 100 KEY INFORMATION - ABBVIE, INC.
  • TABLE 101 KEY INFORMATION - AMGEN, INC.
  • TABLE 102 KEY INFORMATION - NOVARTIS AG

LIST OF FIGURES

  • FIG 1 METHODOLOGY FOR THE RESEARCH
Back to Top